REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 42 filers reported holding REATA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,781,000 | +192.6% | 18,500 | +35.0% | 0.44% | +392.2% |
| Q2 2019 | $1,292,000 | +10.4% | 13,700 | 0.0% | 0.09% | +66.7% |
| Q1 2019 | $1,170,000 | +117.5% | 13,700 | +42.7% | 0.05% | +45.9% |
| Q4 2018 | $538,000 | -20.5% | 9,600 | -72.0% | 0.04% | -41.3% |
| Q2 2016 | $677,000 | – | 34,300 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
| IFP Advisors, Inc | 300 | $51,708 | 0.00% |